1 |
Cammarota M, Ferlenghi F, Vacondio F, Vincenzi F, Varani K, Bedini A, Rivara S, Mor M, Boscia F. Combined targeting of fatty acid amide hydrolase and melatonin receptors promotes neuroprotection and stimulates inflammation resolution in rats. Br J Pharmacol 2022. [PMID: 36526591 DOI: 10.1111/bph.16014] [Reference Citation Analysis]
|
2 |
Boda E, Boscia F, Lohr C. Editorial: The Role of Astroglia and Oligodendroglia in CNS Development, Plasticity, and Disease – Novel Tools and Investigative Approaches. Front Cell Neurosci 2022;16:901820. [DOI: 10.3389/fncel.2022.901820] [Reference Citation Analysis]
|
3 |
Singh SP, William M, Malavia M, Chu X. Behavior of KCNQ Channels in Neural Plasticity and Motor Disorders. Membranes 2022;12:499. [DOI: 10.3390/membranes12050499] [Reference Citation Analysis]
|
4 |
Elkjaer ML, Röttger R, Baumbach J, Illes Z. A Systematic Review of Tissue and Single Cell Transcriptome/Proteome Studies of the Brain in Multiple Sclerosis. Front Immunol 2022;13:761225. [PMID: 35309325 DOI: 10.3389/fimmu.2022.761225] [Reference Citation Analysis]
|
5 |
Radomski KL, Zi X, Lischka FW, Noble MD, Galdzicki Z, Armstrong RC. Acute axon damage and demyelination are mitigated by 4-aminopyridine (4-AP) therapy after experimental traumatic brain injury. Acta Neuropathol Commun 2022;10:67. [PMID: 35501931 DOI: 10.1186/s40478-022-01366-z] [Reference Citation Analysis]
|
6 |
Radomski KL, Zi X, Lischka FW, Noble MD, Galdzicki Z, Armstrong RC. Acute Axon Damage and Demyelination are Mitigated by 4-Aminopyridine (4-AP) Therapy after Experimental Traumatic Brain Injury.. [DOI: 10.1101/2022.01.27.477989] [Reference Citation Analysis]
|